In the original article, there was a mistake in “Figure 2C” as published. In the figure legend, the incorrect number was used to indicate the second-best route and should have been “5.22 €M” instead of “5.97 €M”. The corrected Figure 2C appears below.
Figure 2
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Summary
Keywords
vaccine, malaria, product development (PD) process, clinical development, low-income access
Citation
Roestenberg M, Kamerling IMC and de Visser SJ (2019) Corrigendum: Controlled Human Infections As a Tool to Reduce Uncertainty in Clinical Vaccine Development. Front. Med. 6:23. doi: 10.3389/fmed.2019.00023
Received
09 January 2019
Accepted
25 January 2019
Published
14 February 2019
Volume
6 - 2019
Edited and reviewed by
Berent Prakken, Utrecht University, Netherlands
Updates
Copyright
© 2019 Roestenberg, Kamerling and de Visser.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Meta Roestenberg m.roestenberg@lumc.nl
This article was submitted to Translational Medicine, a section of the journal Frontiers in Medicine
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.